Fulgent Genetics (FLGT) News Today $18.39 +0.02 (+0.11%) (As of 12:56 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Fulgent Genetics: High Insider Ownership Supports Asymmetric UpsideDecember 24, 2024 | seekingalpha.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Purchased by Barclays PLCBarclays PLC grew its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 22.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 174,855 shares of the company's stock after acquiring an additional 32,250 shares during the period. Barclays PDecember 23, 2024 | marketbeat.comWith 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backingDecember 21, 2024 | uk.finance.yahoo.comFulgent Genetics: A Value Stock With Caveats (Rating Downgrade)December 19, 2024 | seekingalpha.comShort Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Increases By 29.3%Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 748,900 shares, an increase of 29.3% from the November 15th total of 579,100 shares. Approximately 3.8% of the company's stock are sold short. Based on an average daily trading volume, of 203,600 shares, the short-interest ratio is currently 3.7 days.December 15, 2024 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Purchased by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 220.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,813 shares of the company's stock after acquiDecember 11, 2024 | marketbeat.comPoint72 Asset Management L.P. Purchases New Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT)Point72 Asset Management L.P. acquired a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 269,375 shares of the company's stock, valued at approximately $5,854,000. Point72December 9, 2024 | marketbeat.comJian Xie Sells 689 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) StockNovember 28, 2024 | insidertrades.comStockNews.com Downgrades Fulgent Genetics (NASDAQ:FLGT) to SellStockNews.com downgraded shares of Fulgent Genetics from a "hold" rating to a "sell" rating in a report on Wednesday.November 27, 2024 | marketbeat.comFulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right NowNovember 20, 2024 | msn.comFulgent Genetics (NASDAQ:FLGT) Sets New 12-Month Low - Here's WhyFulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Here's WhyNovember 19, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by StockNews.comStockNews.com raised Fulgent Genetics from a "sell" rating to a "hold" rating in a report on Tuesday.November 19, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Shares Up 4% - Still a Buy?Fulgent Genetics (NASDAQ:FLGT) Shares Up 4% - Should You Buy?November 15, 2024 | marketbeat.comFulgent Genetics price target lowered to $22 from $26 at Piper SandlerNovember 13, 2024 | markets.businessinsider.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comFulgent Genetics (NASDAQ:FLGT) Given New $22.00 Price Target at Piper SandlerPiper Sandler dropped their price objective on Fulgent Genetics from $26.00 to $22.00 and set a "neutral" rating for the company in a research report on Monday.November 11, 2024 | marketbeat.comFulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | seekingalpha.comCompanies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In GrowthNovember 10, 2024 | finance.yahoo.comFulgent Genetics Reports Q3 2024 Financial PerformanceNovember 10, 2024 | markets.businessinsider.comFulgent Genetics Reports Strong Q3 2024 ResultsNovember 10, 2024 | finance.yahoo.comFulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue DeclineNovember 10, 2024 | finance.yahoo.comFulgent Genetics (NASDAQ:FLGT) Trading Down 10.8% - Time to Sell?Fulgent Genetics (NASDAQ:FLGT) Trading Down 10.8% - Time to Sell?November 8, 2024 | marketbeat.comFulgent Reports Third Quarter 2024 Financial ResultsNovember 8, 2024 | finanznachrichten.deFulgent Genetics: EPS Exceeds ForecastNovember 8, 2024 | fool.comFulgent Genetics (NASDAQ:FLGT) Releases FY24 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY24 earnings guidance. The company provided EPS guidance of $0.33 for the period, compared to the consensus estimate of ($0.39).November 8, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Releases FY 2024 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.330-0.330 for the period, compared to the consensus estimate of -0.390. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $282.2 millionillion.November 8, 2024 | marketbeat.comUncovering Potential: Fulgent Genetics's Earnings PreviewNovember 7, 2024 | benzinga.comFulgent to Participate in Upcoming ConferencesNovember 5, 2024 | finance.yahoo.comFulgent Genetics (FLGT) Scheduled to Post Quarterly Earnings on FridayFulgent Genetics (NASDAQ:FLGT) will be releasing earnings before the market opens on Friday, November 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636991)November 1, 2024 | marketbeat.comFulgent Genetics Inc.October 31, 2024 | wsj.comFulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to VeteransOctober 31, 2024 | businesswire.comFulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1October 31, 2024 | businesswire.comShort Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Grows By 5.6%Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 676,100 shares, an increase of 5.6% from the September 30th total of 640,100 shares. Based on an average daily trading volume, of 145,900 shares, the short-interest ratio is currently 4.6 days. Currently, 3.4% of the shares of the company are short sold.October 31, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Here's WhyFulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Time to Sell?October 24, 2024 | marketbeat.comFulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024October 17, 2024 | businesswire.comFulgent Genetics, Inc. (NASDAQ:FLGT) Sees Significant Drop in Short InterestFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 640,100 shares, a decline of 11.5% from the September 15th total of 723,200 shares. Currently, 3.2% of the company's shares are short sold. Based on an average trading volume of 166,300 shares, the short-interest ratio is presently 3.8 days.October 15, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Stock Quotes, Forecast and News SummaryOctober 14, 2024 | benzinga.comFulgent Genetics (NASDAQ:FLGT) Stock, Short Interest ReportOctober 14, 2024 | benzinga.comMillennium Management LLC Has $18.81 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)Millennium Management LLC grew its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 34.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 958,852 shares of theOctober 6, 2024 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Algert Global LLCAlgert Global LLC boosted its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 46.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,440 shares of the company's stock after acqOctober 4, 2024 | marketbeat.comCaxton Associates LP Purchases Shares of 25,095 Fulgent Genetics, Inc. (NASDAQ:FLGT)Caxton Associates LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,095 shares of the company's stock, valued at approximatSeptember 28, 2024 | marketbeat.comDivisadero Street Capital Management LP Acquires 160,212 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)Divisadero Street Capital Management LP raised its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 46.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 505,212 shares of the company's stock after purchasing an additional 160September 20, 2024 | marketbeat.comThose who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107%September 18, 2024 | finance.yahoo.comAcadian Asset Management LLC Acquires 53,680 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)Acadian Asset Management LLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 593.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 62,724 shares of the company's stock after acquiSeptember 16, 2024 | marketbeat.comBank of New York Mellon Corp Has $3.95 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)Bank of New York Mellon Corp increased its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 37.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 201,201 shares of the company'sSeptember 15, 2024 | marketbeat.comFulgent Genetics: Core Growth Re-Acceleration Will Be The Critical CatalystSeptember 9, 2024 | seekingalpha.comAcuitas Investments LLC Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Acuitas Investments LLC acquired a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 49,016 shares of the company's stock, valued at approximately $962,000.September 6, 2024 | marketbeat.comHanlin Gao Sells 563 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) StockAugust 30, 2024 | insidertrades.comJian Xie Sells 715 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) StockAugust 30, 2024 | insidertrades.comFulgent Genetics (FLGT) Earnings Dates & ReportsAugust 9, 2024 | investing.com Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Altcoin season moves fast, and those who hesitate are left behind. The window is closing. >> Register for the Workshop Now FLGT Media Mentions By Week FLGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FLGT News Sentiment▼0.510.59▲Average Medical News Sentiment FLGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FLGT Articles This Week▼22▲FLGT Articles Average Week Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARDT News Today WGS News Today PACS News Today NHC News Today FTRE News Today TDOC News Today VRDN News Today AHCO News Today CDNA News Today PNTG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FLGT) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Elon Spotted at Weird Facility in Memphis? What Elon Musk is planning at a remote facility in Memphis may be his greatest achievement to date. Because...Paradigm Press | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
